News

Family of 17-year-old Karmelo Anthony, who is accused of fatally stabbing fellow teen Austin Metcalf at a Texas track meet, ...
When the study ended, weight loss did not plateau, suggesting that patients may continue to lose weight, Lilly said.
A 13-year-old boy died following an accident involving an occupied school bus on a South Carolina highway, according to the ...
Ahn’s take on The Wedding Banquet follows a close-knit group of cohabiting Seattlites—couples Lee (Gladstone) and Angela ...
The successful trial of a daily weight-loss pill has been hailed as a “landmark moment” in the fight against obesity, with ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
CNBC's Angelica Peebles joins 'Fast Money' to talk the latest on oral GLP-1 trials.
NEW YORK (AP) — Most U.S. stocks climbed Thursday, but the worst drop for UnitedHealth Group in a quarter of a century kept ...
Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...
A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, Wegovy, Mounjaro and Zepbound, a clinical trial shows.
Collaboration combines BigHat's AL/ML-powered Milliner™ platform with Lilly's expertise in drug discovery to develop high-quality next-generation antibodies. SAN MATEO, Calif.--(BUSINESS WIRE)--BigHat ...